Evidence map›Paper›PMID 40375351›Full record

ArticleAlzheimer's research & therapy2025

tRF

Zihao Deng, Yudi Li, Wenjun Chi, Wanzhou Zhang, Fangming Li, Li Ling

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zihao DengDepartment of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, 518000, China.ORCID 0009-0000-2681-7180
Yudi LiDepartment of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, 518000, China.ORCID 0000-0002-0324-6888
Wenjun ChiDepartment of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, 518000, China.ORCID 0009-0001-4132-1586
Wanzhou ZhangDepartment of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, 518000, China.ORCID 0000-0001-8050-9496
Fangming Li *Department of Neurology, Clinical Medical Academy, Shenzhen University General Hospital, Shenzhen University, Shenzhen, 518000, China. lifly050413@163.com.ORCID 0009-0005-7398-6960
Li Ling *Department of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, 518000, China. linglirabbit@163.com.ORCID 0000-0001-7238-9578

Funding

Guangdong Provincial Basic and Applied Basic Research Foundation 2021A1515220074Science and Technology Project of Shenzhen JCYJ20210324131614038Shenzhen Key Medical Discipline Construction Fund SZXK074
6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) is a chronic, progressive neurodegenerative disorder clinically characterized by memory decline, cognitive dysfunction, language impairment, deterioration of visuospatial skills, and personality changes. Pathologically, AD is marked by the deposition of β-amyloid (Aβ) plaques in the brain, the formation of neurofibrillary tangles, and progressive neuronal loss. Recent research has highlighted transfer RNA (tRNA)-derived small RNAs (tsRNAs) as crucial regulators in various biological processes; however, their roles in the pathophysiology of AD remain largely unexplored. The erythropoietin-producing hepatocellular (Eph) receptor family has recently drawn attention in the study of neurodegenerative diseases due to their role in regulating critical processes, including cell migration, neural development, angiogenesis, and tumor formation. This study aimed to investigate specific tsRNAs associated with AD by performing RNA sequencing on the cortex of APP/PS1 transgenic mice and to explore the relationship between tsRNAs and their target genes within the Eph receptor family, thereby elucidating insights into the specific regulatory functions of these molecules.

methodsEight-month-old male C57BL/6 and APP/PS1 transgenic mice were used in the study. BV-2 and HT22 cells were cultured and treated with Aβ

resultsWe identified for the first time that EphA7 expression is upregulated in aggregated microglia and neuronal cells in the dentate gyrus region of the hippocampus, with increased phosphorylation of ERK

conclusionsThis study clarifies the specific role of tRF

Indexed as

Alzheimer DiseaseMAP Kinase Signaling SystemNeuroinflammatory DiseasesNeuronsAmyloid beta-PeptidesAnimalsHumansMaleMiceMice, Inbred C57BLMice, TransgenicSignal TransductionAmyloid beta-PeptidesAlzheimer’s diseaseEphA7ERK1/2MicrogliaNeuroinflammationp70S6KtRFAla-AGC-3-M8tsRNA

Identifiers

PMID40375351
PMCPMC12079980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.